STOCK TITAN

Editas Medicine, Inc. (EDIT) Net Income by Year

EDIT

Editas Medicine, Inc. reported a net loss of $160.1M in fiscal year 2025. This represents an increase of 32.5% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $73.9M net loss. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Editas Medicine, Inc. has filed alongside them.

FY2025 annual
Net Income -$160.1M
YoY +32.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

EDIT Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$73.9M-$160.1M+32.5%-$237.1M-54.7%-$153.2M+30.5%-$220.4M-14.5%-$192.5M-66.0%-$116.0M+13.3%-$133.7M-21.6%-$110.0M+8.6%-$120.3M-23.8%-$97.2M-33.3%-$72.9M-432.7%-$13.7M

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

EDIT Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$18.2M+65.8%-$25.0M+67.2%-$5.6M+87.6%-$25.1M+59.6%-$53.2M+21.3%-$76.1M-22.8%-$45.4M-140.5%-$62.1M-38.0%-$67.6M-67.8%-$62.0M-26.3%-$18.9M+68.9%-$45.0M+19.2%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Editas Medicine, Inc. financials

Frequently Asked Questions

What was Editas Medicine, Inc.'s net income in fiscal year 2025?

Editas Medicine, Inc. reported a net loss of $160.1M in fiscal year 2025.

How fast is Editas Medicine, Inc.'s net income growing?

Editas Medicine, Inc. (EDIT) net income rose by 32.5% year over year, from -$237.1M to -$160.1M in fiscal year 2025.

What is Editas Medicine, Inc.'s net income over the last twelve months?

Editas Medicine, Inc. (EDIT) reported a $73.9M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.

Across the 12 fiscal years this page covers, Editas Medicine, Inc. (EDIT) net income went from -$13.7M in fiscal year 2014 to -$160.1M in fiscal year 2025.

Editas Medicine, Inc. (EDIT) reported -$18.2M in net income in Q2 2026. This represents an increase of 65.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Editas Medicine, Inc. (EDIT) reported on that line in every period on record.